Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (Q3)Nov 30, 2025 | (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -83.45%-272.41K | 29.19%-173.64K | 47.88%-67.39K | 63.74%-599.64K | 60.52%-76.62K | 64.99%-148.5K | 57.51%-245.22K | 71.79%-129.3K | 5.68%-1.65M | 65.79%-194.09K |
| Net income from continuing operations | 47.51%-272.32K | 91.90%-299.24K | 1.24%-270.23K | -92.79%-5.27M | -111.37%-783.33K | 43.83%-518.81K | -680.47%-3.69M | 71.68%-273.61K | -15.65%-2.73M | 63.80%-370.59K |
| Operating gains losses | --17.63K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -25.93%100 | -25.19%101 | -25.74%101 | -25.85%542 | -25.68%136 | -32.84%135 | -19.64%135 | -24.02%136 | -13.59%731 | -4.19%183 |
| Asset impairment expenditure | --0 | ---- | ---- | --4.47M | --675.32K | --373.59K | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | --0 | --0 | --0 | -92.88%52.19K | --0 | --0 | --0 | -79.23%52.19K | -6.47%733.31K | -67.73%136.11K |
| Other non cashItems | 81.71%-18.77K | -5,536.84%-173.67K | 2,189.27%88.17K | 7.87%-119.56K | 93.73%-9.64K | -5,826.73%-102.62K | -155.32%-3.08K | -125.33%-4.22K | -138.58%-129.77K | -7,659.54%-153.79K |
| Change In working capital | -99.04%950 | 82.03%55.22K | 19.09%114.57K | -43.97%266.64K | -78.92%40.9K | -34.54%99.2K | 127.71%30.34K | -59.88%96.21K | 496.88%475.87K | 432.27%194K |
| -Change in receivables | -115.29%-13.97K | 154.71%8.04K | 123.81%3.02K | 368.57%101.24K | 129.99%37.3K | 41.38%91.31K | 42.93%-14.69K | -126.50%-12.68K | 25.52%-37.7K | -84.33%-124.37K |
| -Change in prepaid assets | 145.96%21.6K | 172.21%34.3K | 128.00%13.42K | -134.72%-114.42K | -80.10%28K | -120.01%-47K | 61.17%-47.5K | -162.82%-47.92K | 204.15%329.53K | 263.02%140.69K |
| -Change in payables and accrued expense | -112.18%-6.69K | -86.08%12.88K | -37.41%98.14K | 52.04%279.82K | -113.73%-24.4K | 137.10%54.89K | 139.64%92.53K | 35.54%156.8K | -25.52%184.04K | -6.60%177.68K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -83.45%-272.41K | 29.19%-173.64K | 47.88%-67.39K | 63.74%-599.64K | 60.52%-76.62K | 64.99%-148.5K | 57.51%-245.22K | 71.79%-129.3K | 5.68%-1.65M | 65.79%-194.09K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 436.44%305.27K | -751.06%-111.45K | 1,266.38%382K | 103.72%44.77K | 104.98%33.71K | 134.50%56.91K | 75.91%-13.1K | 89.30%-32.75K | -174.72%-1.2M | -84.28%-676.73K |
| Capital expenditure reported | ---- | -751.06%-111.45K | 45.04%-18K | ---- | ---- | ---- | ---13.1K | ---32.75K | ---- | ---- |
| Net PPE purchase and sale | -1,395.80%-143.33K | --0 | --400K | --100K | -83.07%88.94K | 106.71%11.06K | --0 | --0 | --0 | --525.33K |
| Net business purchase and sale | ---- | ---- | ---- | --58.71K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | 90.52%-113.94K | ---- | ---- | ---- | 89.30%-32.75K | -174.72%-1.2M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 436.44%305.27K | -751.06%-111.45K | 1,266.38%382K | 103.72%44.77K | 104.98%33.71K | 134.50%56.91K | 75.91%-13.1K | 89.30%-32.75K | -174.72%-1.2M | -84.28%-676.73K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 25.48%-1K | -99.65%1K | -127.87%-40K | -80.59%464.8K | -95.21%40K | -101.70%-1.34K | -76.34%282.64K | -50.00%143.5K | -8.56%2.39M | 62.75%834.56K |
| Net issuance payments of debt | ---1K | 102.00%1K | ---40K | -110.00%-10K | -63.64%40K | --0 | ---50K | --0 | --100K | --110K |
| Net common stock issuance | --0 | --0 | --0 | -78.45%469K | --0 | --0 | -70.30%349K | -49.21%120K | -17.44%2.18M | 48.18%765.3K |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -85.39%27.5K | --0 | --0 | --0 | -45.81%27.5K | 65.88%188.27K | -76.21%27K |
| Net other financing activities | ---- | ---- | ---- | 68.96%-21.7K | --0 | -113.42%-1.34K | ---16.36K | ---4K | 46.50%-69.9K | 42.19%-67.74K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 25.48%-1K | -99.65%1K | -127.87%-40K | -80.59%464.8K | -95.21%40K | -101.70%-1.34K | -76.34%282.64K | -50.00%143.5K | -8.56%2.39M | 62.75%834.56K |
| Net cash flow | ||||||||||
| Beginning cash position | -97.68%2.5K | 243.20%286.59K | -88.26%11.98K | -81.87%102.06K | -89.23%14.9K | -83.38%107.82K | -2.37%83.51K | -81.87%102.06K | 318.36%562.84K | -85.95%138.31K |
| Current changes in cash | 134.29%31.86K | -1,268.27%-284.09K | 1,580.36%274.61K | 80.45%-90.07K | 91.96%-2.92K | 81.79%-92.92K | -95.68%24.32K | 96.11%-18.55K | -207.58%-460.78K | 91.40%-36.26K |
| End cash Position | 130.61%34.36K | -97.68%2.5K | 243.20%286.59K | -88.26%11.98K | -88.26%11.98K | -89.23%14.9K | -83.38%107.82K | -2.37%83.51K | -81.87%102.06K | -81.87%102.06K |
| Free cash from | -49.43%-286.3K | -10.36%-285.09K | 47.30%-85.39K | 63.74%-599.64K | -96.28%12.32K | 67.48%-191.59K | 72.45%-258.32K | 64.64%-162.05K | 5.68%-1.65M | 167.33%331.24K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.